Brielle Benyon | Authors

Articles

Daratumumab Added to RVd Achieved MRD Negativity, PFS Improvement in Newly Diagnosed Myeloma

June 05, 2022

Among patients with newly diagnosed, transplant-eligible myeloma treated in a phase 2 study, induction and consolidation with daratumumab plus the RVd regimen outperformed RVd alone in terms of minimal residual disease and progression-free survival.

Multimodal Therapy Explored in Unresectable HCC

March 29, 2022

Findings from the use of mutimodal interventional therapy of lenvatinib and transarterial therapy may lay the groundwork for future research regarding the combination for the treatment of patients with hepatocellular carcinoma.